Related references
Note: Only part of the references are listed.Toll-Like Receptor 4 Deficiency Decreases Atherosclerosis But Does Not Protect Against Inflammation in Obese Low-Density Lipoprotein Receptor-Deficient Mice
Yilei Ding et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1
Jenny E. Kanter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Role of Toll-Like Receptor 4 in Intimal Foam Cell Accumulation in Apolipoprotein E-Deficient Mice
Mie Higashimori et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes
Sridevi Devaraj et al.
CYTOKINE (2011)
DPP-4 (CD26) Inhibitor Alogliptin Inhibits Atherosclerosis in Diabetic Apolipoprotein E-Deficient Mice
Nga N. Ta et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Insulin treatment attenuates diabetes-increased atherosclerotic intimal lesions and matrix metalloproteinase 9 expression in apolipoprotein E-deficient mice
Corinne A. Schuyler et al.
JOURNAL OF ENDOCRINOLOGY (2011)
A Volumetric Method for Quantifying Atherosclerosis in Mice by Using MicroCT: Comparison to En Face
David J. Lloyd et al.
PLOS ONE (2011)
Innate immunity and the pathogenesis of type 1 diabetes
Fabio Arturo Grieco et al.
SEMINARS IN IMMUNOPATHOLOGY (2011)
Toll-like receptor 4/nuclear factor-kappa B pathway is involved in myocardial injury in a rat chronic stress model
Rong-Ping Wang et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2011)
Evidence that opioids may have toll-like receptor 4 and MD-2 effects
Mark R. Hutchinson et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Inhibition of Corneal Inflammation by the TLR4 Antagonist Eritoran Tetrasodium (E5564)
Yan Sun et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells
Hamida Hammad et al.
NATURE MEDICINE (2009)
Markers of inflammation and coronary artery calcification: A systematic review
Yasmin S. Hamirani et al.
ATHEROSCLEROSIS (2008)
Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2
A Visintin et al.
JOURNAL OF IMMUNOLOGY (2005)
Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages
YI Miller et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease
MM Fort et al.
JOURNAL OF IMMUNOLOGY (2005)
Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways
H Björkbacka et al.
NATURE MEDICINE (2004)
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
KS Michelsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells
YI Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Analysis of expression of nuclear factor κB (NF-κB) in multiple myeloma:: downregulation of NF-κB induces apoptosis
H Ni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Share Paper
